BETA

Awaiting committee decision



2017/2923(DEA) Adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
RoleCommitteeRapporteurShadows
Lead ENVI
Lead committee dossier: ENVI/8/11337

Activites

  • 2017/10/26 Committee referral announced in Parliament, 1st reading/single reading
  • 2017/10/18 Initial period for examining delegated act 2 month(s)
  • 2017/10/18 Non-legislative basic document published

Documents

History

(these mark the time of scraping, not the official date of the change)

activities/3
date
2018-01-05T00:00:00
body
EP/CSL
type
Delegated act not objected by Parliament
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Council decision on delegated act
activities
  • date: 2017-10-18T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
  • date: 2017-10-18T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/actes_delegues/2017/06946/COM_ADL(2017)06946_EN.pdf type: Non-legislative basic document published title: C(2017)06946 type: Non-legislative basic document published body: EC commission:
  • date: 2017-10-26T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
committees
  • body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
    procedure
    dossier_of_the_committee
    ENVI/8/11337
    reference
    2017/2923(DEA)
    title
    Adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
    stage_reached
    Awaiting committee decision
    summary
    Supplementing
    subtype
    Examination of delegated act
    type
    DEA - Delegated acts procedure
    subject
    4.20.04 Pharmaceutical products and industry